Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 6, 2003

View Archived Issues

Abraxane exceeds primary efficacy objective in phase III trial

Aripiprazole in schizophrenia and bipolar disorder

Treatment completed in phase IIb trial of MBI-594AN for acne

Positive phase I results for Cytovaxine

Biogen licenses rights to oral psoriasis product from Fumapharm

FDA approves Zomig nasal spray

BCY LifeSciences completes treatment in phase II DCF-987 trial

VaxGen awarded anthrax vaccine development contract by NIAID

Atomoxetine hydrochloride in children and adults with ADHD

Lack of synergy described for alendronate and PTH in osteoporosis

Novel NPY Y5 antagonists prepared and tested at Roche

Recent patents cover new 5-HT6 modulators for psychosis, other CNS disorders and imaging

New antibacterial oxazolidinones discovered at P&U (now Pfizer)

Bayer presents two novel series of antitumor agents in recent patent literature

Schering presents new contrast agents for X-ray and NMR

Novel PI3-kinase inhibitors and their use described by Novartis scientists

Abbott seeks approval for Humira for improvement of physical function in RA

Rolling NDA submission continues for RSR-13

Arius and PDL enter cancer antibody development partnership

Medarex and Trillium collaborate on development of antibody therapeutics

Preclinical update provided for ENT-103

Neuprex tested for potential in pediatric open heart surgery

Forest discontinues development of dexloxiglumide for constipation-predominant IBS

Potential new amyloid-imaging agent presented to Japanese Society of Dementia

Anti-HIV candidate with unique resistance profile and promising pharmacokinetics

Inhaled ilomastat prevents cigarette smoke-induced lung damage in mouse model of emphysema

Novel antibacterial agents targeting enoyl-ACP reductase

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...